We are live on ! Find out more
TPI

TIANYIN PHARMACEUTICAL
TPI

Delisted

TPI was delisted on the 29th of April, 2016.

Back to rankings

6 hedge funds and large institutions have $2.86M invested in TIANYIN PHARMACEUTICAL in 2013 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Pope Asset Management
Tennessee
$2.61M +$3.12M +5,298,008 New
Renaissance Technologies
2
Renaissance Technologies
New York
$196K +$234K +398,300 New
CCB
3
Cutter & Co Brokerage
Missouri
$36K +$43.8K +74,400 New
RIM
4
Regent Investment Management
Kentucky
$16K +$19.1K +32,400 New
U
5
UBS
Switzerland
$2K +$1.8K +3,065 New
FA
6
Financial Advantage
Maryland
– +$588 +1,000 New

TPI Hedge Fund Activity: Q2 2013 in Review

6 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q2 2013, worth a combined $2.86M.

Buyers outnumbered sellers: 6 funds opened new TPI positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

  • 6 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.86M of TIANYIN PHARMACEUTICAL stock for Q2 2013.
  • 6 funds opened new TIANYIN PHARMACEUTICAL positions in Q2 2013 and 0 closed out, a net change of +6 holders.

Based on aggregated 13F filings for Q2 2013.